Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Journal article
Jia W. et al, (2024), Nature Communications
Heterologous prime-boost immunization induces protection against dengue virus infection in cynomolgus macaques.
Journal article
Keelapang P. et al, (2023), J Virol, 97
The molecular reach of antibodies determines their SARS-CoV-2 neutralisation potency
Preprint
Huhn A. et al, (2023)
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.
Journal article
Hornsby H. et al, (2023), Nat Commun, 14
Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody.
Journal article
Keelapang P. et al, (2023), Microbiol Spectr, 11
Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.
Journal article
Thursz M. et al, (2023), J Gen Virol, 104
Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2.
Journal article
Thursz M. et al, (2023), J Gen Virol, 104
Accelerating drug target inhibitor discovery with a deep generative foundation model.
Journal article
Chenthamarakshan V. et al, (2023), Sci Adv, 9
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.
Journal article
Ragonnet-Cronin M. et al, (2023), Nat Commun, 14
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.
Journal article
Yin Z. et al, (2023), Cell Rep, 42
COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK
Journal article
BUCKELL J. et al, (2023), Scientific Reports
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Journal article
Wei J. et al, (2023), Nature Communications
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - a single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Journal article
Shaw RH. et al, (2023), J Infect
Isolation of a pair of potent broadly neutralizing mAb binding to RBD and SD1 domains of SARS-CoV-2
Preprint
Stuart D. et al, (2023)
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens.
Journal article
Moore SC. et al, (2023), Med, 4, 191 - 215.e9
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses.
Journal article
Dijokaite-Guraliuc A. et al, (2023), Cell Rep, 42
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.
Journal article
Huo J. et al, (2023), Cell Rep, 42
Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses
Preprint
Hornsby H. et al, (2023)
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.
Journal article
Emmenegger M. et al, (2023), iScience